Although this activity is no longer certified for credit, we believe that it contains important information and hope you'll review, print or email it to a colleague.
SLNB: Decoding the controversies regarding its use and significance
CME Course Duration:
Start Date: January 2009
This activity is directed toward surgical oncologists, general surgeons, oncology nurses, medical oncologists, dermatologists, and other healthcare professionals who treat or screen for melanoma.
Analyze controversies regarding the use of sentinel lymph node biopsy and the interpretation of biopsy findings
Faculty Disclosure Statement
Dr. Robert H. I. Andtbacka has no financial relationships to disclose.
This CME program represents the views and opinions of the individual faculty for each case and does not constitute the opinion or endorsement of the editors, the advisory board, the publishing staff, Paradigm Medical Communications, the UPMC Center for Continuing Education in the Health Sciences, UPMC/University of Pittsburgh Medical Center or affiliates, or University of Pittsburgh School of Medicine.
Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions, including without limitation, FDA-approved uses, and any off-label uses.